Delivery Order SPE2DR25D2104-SPE2DR26F3PCC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,227.00 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiovascular medication used to treat heart failure. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on July 14, 2025, with an ultimate completion date of July 15, 2025. The delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,454.26 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiovascular medication used to treat heart failure. The contract was awarded on April 23, 2025, with an ultimate completion date of April 24, 2025, and employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a $5,533.86 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 7.5 mg, a cardiovascular medication used to treat heart failure. This firm fixed-price contract, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, was competitively awarded without set-aside restrictions. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $7,495 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiac medication used to treat heart failure. This competitively awarded, firm fixed-price contract was issued on June 17, 2025, with an ultimate completion date of June 18, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $8,386.17 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a pharmaceutical product for cardiovascular treatment. This non-set-aside contract was competitively awarded on June 4, 2025, with an ultimate completion date of June 5, 2025, and is priced on a firm fixed-price basis. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.18 to AmerisourceBergen Drug Corp for Corlanor 5 mg tablets (60-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing federal contract portfolio with DLA. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,605.38 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiovascular medication used to treat heart failure. This contract type represents a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and was awarded on August 22, 2025. The award was made without a set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Corlanor 5 mg tablets (60-count) valued at $5,060.71. This firm fixed-price delivery order, with an ultimate completion date of October 24, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the DLA. The award was made through open competition with no set-aside designation, and performance will be executed from the...
- The Defense Logistics Agency awarded a $1,549.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Corlanor 5 mg tablets (60-count). This is a non-set-aside contract with an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Corlanor 5 mg tablets (60-count unit) valued at $4,410.48 under a firm fixed-price contract type. This award represents a competitively awarded, non-set-aside delivery order with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PCCDelivery Order
The Defense Logistics Agency awarded a $2,304.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiac medication used to treat heart failure. The contract, which is a child order under a larger indefinite delivery vehicle, was competitively awarded without set-aside designation and is scheduled for completion by November 17, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a wide range of medications and medical supplies to support military healthcare programs and other government healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of federal awards demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains on behalf of the Department of Defense and related federal health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/14/25 |